28.04.2011 • NewsMerck & Co.Kenneth Frazierportfolio

Merck & Co to Buy Back Up To $5 Billion Of Its Shares

Merck & Co said on Wednesday it plans to buy back up to $5 billion in shares, bringing its total share buyback program to $6.4 billion.
The Whitehouse Station, New Jersey-based drugmaker said the stock purchase has no time limit and will be made on the open market, in block transactions or privately negotiated transactions.

"Merck has a history of leadership in returning cash to shareholders," said Kenneth Frazier, Merck's chief executive officer. "Today's action reflects our confidence in Merck's strategy and demonstrates our commitment to delivering shareholder value."

The company still has $1.4 billion remaining from a share repurchase authorization announced in November 2009.

Company

Logo:

Merck & Co

126 East Lincoln Avenue
07065 Rahway
US

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.